Fertility and endocrinopathies among adults with β-thalassemia major treated at Dubai thalassemia center
-
By
-
Rabah Almahmoud
-
Amal Hussein
-
Fatheya Al Khaja
-
Ahmed Farrag Soliman
-
Hany Dewedar
-
Sarah Mathai
-
July 2, 2026
-
Clinical Scorecard: Endocrine Disorders and Reproductive Health in Adults with β-Thalassemia Major at a Thalassemia Treatment Center in Dubai
At a Glance
| Category | Detail |
|---|
| Condition | β-thalassemia major |
| Key Mechanisms | Iron overload in the endocrine system leading to various endocrinopathies. |
| Target Population | Adults with β-thalassemia major aged above 18 years. |
| Care Setting | Thalassemia treatment center. |
Key Highlights
- Remove unsupported claims or ensure they are directly sourced.
- Verify the accuracy of prevalence statistics.
Guideline-Based Recommendations
Diagnosis
- Diagnosis based on clinical suspicion and laboratory findings including hypochromic microcytic anemia.
Management
- Regular blood transfusions and iron chelation therapy to manage iron overload.
Monitoring & Follow-up
- Monitor endocrine function and iron levels regularly to prevent complications.
Risks
- Poor chelation increases the risk of developing hypothyroidism and other endocrinopathies.
Patient & Prescribing Data
Adults with β-thalassemia major receiving treatment at a thalassemia center.
Chelation therapy is crucial to reduce the risk of endocrine complications.
Clinical Best Practices
- Emphasize compliance with chelation therapy.
- Conduct regular endocrine assessments in patients with β-thalassemia major.
Related Resources & Content
